conduct
studi
among
healthcar
worker
hcw
expos
patient
sever
acut
respiratori
syndrom
sar
infect
control
measur
institut
expos
hcw
asymptomat
sarsposit
case
asymptomat
sar
associ
lower
sar
antibodi
titer
higher
use
mask
compar
pneumon
sar
pattern
spread
sever
acut
respiratori
syndrom
sar
suggest
droplet
contact
transmiss
close
proxim
person
handl
human
secret
respiratori
secret
fece
like
enhanc
risk
transmiss
fact
togeth
fact
transmiss
like
sever
ill
peopl
end
hospit
made
hospit
set
particularli
vulner
rapid
amplif
sar
singapor
one
countri
affect
worldwid
outbreak
sar
total
case
avail
infect
acquir
healthcar
facil
clinic
spectrum
sar
strong
predomin
toward
sever
diseas
associ
pneumonia
report
incid
asymptomat
mild
infect
attribut
sarsassoci
coronaviru
cov
conflict
conduct
seroepidemiolog
cohort
studi
among
healthcar
worker
hcw
expos
sar
patient
first
month
nosocomi
sar
outbreak
tan
tock
seng
hospit
singapor
studi
goal
investig
incid
factor
associ
asymptomat
sarscov
infect
three
patient
sar
admit
ward
hospit
earli
march
time
sar
recogn
infect
control
measur
place
patient
import
sar
hong
kong
admit
march
isol
day
patient
nurs
look
patient
initi
misdiagnos
dengu
isol
day
admiss
sar
suspect
patient
admit
reason
septicemia
ischem
heart
diseas
diabet
share
cubicl
patient
becam
infect
isol
day
later
sinc
initi
diagnosi
sar
consid
march
onward
hcw
use
mask
gown
glove
person
protect
nurs
patient
person
suspect
sar
meant
provid
nurs
care
patient
hcw
use
person
protect
measur
sar
suspect
suspect
patient
isol
march
mask
gown
glove
mandatori
hcw
patient
contact
hospit
inform
staff
work
ward
march
retriev
outbreak
investig
team
hospit
human
resourc
hcw
exposur
patient
includ
exposur
defin
contact
patient
room
cubicl
telephon
interview
conduct
april
use
close
questionnair
staff
experienc
epidemiolog
investig
hospit
depart
clinic
epidemiolog
inform
collect
includ
demograph
data
age
sex
ethnic
group
occup
histori
medic
condit
histori
perform
procedur
transmiss
risk
date
place
type
durat
frequenc
contact
time
defin
total
time
room
l
patient
studi
particip
survey
use
person
protect
ie
wear
mask
glove
gown
consist
handwash
verifi
exposur
name
sourc
patient
includ
questionnair
respond
ask
care
patient
close
within
room
without
direct
exposur
exclud
studi
venou
serum
sampl
taken
may
june
week
exposur
inform
written
consent
given
serum
sampl
test
serolog
sarscov
total
antibodi
enzymelink
immunosorb
assay
elisa
use
sarscovinfect
vero
cell
lysat
uninfect
vero
cell
lysat
suppli
center
diseas
control
prevent
conjug
use
goat
antihuman
immunoglobulin
ig
igg
igm
conjug
horseradish
peroxidas
kirkegaard
perri
laboratori
inc
gaithersburg
md
usa
sampl
posit
sar
repeat
confirm
use
indirect
immunofluoresc
assay
specif
elisa
test
serum
sampl
patient
admit
nonsar
hospit
ill
respiratori
problem
test
igg
igg
neg
sampl
initi
posit
patient
sar
outbreak
sent
nation
environ
agenc
singapor
confirm
neutral
test
found
good
correl
data
shown
laboratori
personnel
blind
clinic
data
patient
posit
sar
serolog
result
fever
respiratori
symptom
radiolog
chang
consist
pneumonia
defin
pneumon
sar
sarscovposit
patient
fever
respiratori
symptom
without
radiolog
chang
defin
subclin
nonpneumon
sar
sarscovposit
patient
without
fever
respiratori
symptom
defin
asymptomat
sarscov
infect
studi
approv
ethic
committe
tan
tock
seng
hospit
total
hcw
identifi
outbreak
team
consent
answer
questionnair
also
consent
sar
serolog
test
perform
sar
serolog
test
differ
test
term
age
sex
job
contact
time
median
age
studi
particip
year
rang
femal
eight
doctor
nurs
staff
staff
nurs
assist
nurs
healthcar
assist
occup
cleaner
radiolog
technician
physiotherapist
report
contact
index
sar
patient
distanc
sourc
patient
case
case
index
case
result
similar
number
secondari
case
rang
secondari
case
hospit
staff
posit
sar
serolog
sarscovposit
studi
particip
classifi
pneumon
sar
subclin
sar
asymptomat
sarscov
infect
tabl
four
staff
member
fever
cough
neg
sar
serolog
test
result
none
diagnos
suspect
sar
hospit
sar
outbreak
team
overal
incid
asymptomat
sarscov
infect
incid
sarscovposit
case
among
asymptomat
hcw
median
titer
sar
antibodi
rang
pneumon
sar
rang
subclin
sar
case
rang
asymptomat
case
tabl
antibodi
titer
asymptomat
case
significantli
lower
pneumon
sar
case
mannwhitney
test
p
univari
analysi
sex
age
use
glove
handwash
contact
l
initi
patient
distanc
patient
contact
time
associ
asymptomat
sar
howev
higher
proport
asymptomat
sar
use
mask
compar
pneumon
sar
develop
p
tabl
found
substanti
number
case
asymptomat
sarscov
infect
subclin
nonpneumon
sar
initi
outbreak
sar
tan
tock
seng
hospit
singapor
incid
asymptomat
case
among
expos
hcw
proport
asymptomat
case
sarscovposit
case
find
regard
asymptomat
subclin
sarscovposit
hcw
contradict
result
previou
studi
report
absenc
asymptomat
sar
case
agre
result
studi
incid
rate
higher
although
significantli
report
asymptomat
hcw
care
sar
patient
hong
kong
differ
like
due
greater
extent
exposur
larg
proport
cohort
close
unprotect
contact
sar
patient
infect
control
measur
place
howev
direct
comparison
possibl
exposur
describ
hong
kong
cohort
extent
exposur
cohort
also
contribut
high
attack
rate
observ
fals
posit
may
also
play
role
unlik
minim
given
high
specif
essay
report
high
specif
center
overal
rate
asymptomat
sar
case
among
sarsposit
case
lower
rate
asymptomat
case
mani
viral
respiratori
diseas
differ
may
explain
novelti
emerg
pathogen
minim
genet
related
coronavirus
human
anim
lack
crossprotect
immun
may
associ
develop
overt
diseas
howev
studi
report
subclin
sarscov
infect
may
common
sarscov
pneumonia
sensit
elisa
sarscov
use
investig
differ
asymptomat
sarscov
infect
pneumon
sar
found
differ
pneumon
sar
patient
asymptomat
sarscovposit
patient
relat
age
durat
distanc
exposur
sourc
patient
handwash
use
glove
find
indic
hcw
expos
sar
infect
sar
regardless
intens
exposur
howev
mask
use
significantli
common
asymptomat
sarsposit
versu
pneumon
sarsposit
patient
antibodi
titer
sarscov
significantli
lower
remain
asymptomat
consist
report
hong
kong
person
lowest
sar
antibodi
titer
cohort
one
indirect
contact
initi
patient
remain
asymptomat
observ
suggest
extent
exposur
sar
person
remain
asymptomat
may
lower
possibl
result
lower
viral
load
sarscov
associ
less
sever
symptom
correl
viral
load
diseas
sever
suggest
howev
hypothesi
remain
controversi
develop
sever
respiratori
distress
also
thought
due
overwhelm
immunolog
respons
higher
viral
load
associ
increas
sever
viral
diseas
associ
infect
dose
sarscov
sever
diseas
need
confirm
anim
studi
low
antibodi
level
observ
asymptomat
sarsposit
case
could
also
asymptomat
patient
mount
much
antibodi
respons
also
possibl
crossreact
antibodi
measur
although
unlik
given
high
specif
assay
exist
asymptomat
subclin
case
public
health
implic
may
either
serv
reservoir
unknown
sourc
transmiss
asymptomat
person
contribut
substanti
transmiss
readili
identifi
sar
control
measur
hamper
sinc
depend
readi
identif
person
expos
definit
case
base
data
singapor
transmiss
asymptomat
patient
appear
play
minor
role
pneumon
case
sar
definit
epidemiolog
link
anoth
pneumon
sar
contact
lack
transmiss
asymptomat
patient
also
observ
countri
sar
outbreak
http
wwwwhointcsrsarsenwhoconsensuspdf
surviv
abil
sarscov
human
specimen
environ
seem
rel
strong
determin
whether
asymptomat
patient
excret
sarscov
import
unabl
determin
cohort
sinc
case
occur
time
even
causal
agent
sar
yet
known
diagnost
test
avail
document
substanti
incid
asymptomat
sarscov
infect
expos
healthcar
worker
full
infect
control
place
asymptomat
sarscov
infect
associ
lower
sar
antibodi
titer
better
protect
measur
mask
compar
pneumon
sar
project
fund
sar
outbreak
fund
tan
tock
seng
hospit
singapor
fund
sourc
role
studi
design
data
interpret
aw
respons
bloodtak
data
analysi
interpret
write
paper
mdt
bhh
respons
questionnair
data
entri
ael
sar
serolog
ae
data
analysi
ysl
initi
lead
studi
author
critic
review
final
paper
dr
wildersmith
resid
physician
infecti
diseas
special
interest
travel
intern
health
research
interest
includ
meningococc
diseas
travelrel
problem
dengu
sar
